Suppr超能文献

恰加斯病血清改变哇巴因对离体大鼠心房的作用。肾上腺素能机制的参与。

Chagasic sera alter the effects of ouabain on isolated rat atria. Participation of adrenergic mechanisms.

作者信息

Sterin-Borda L, Canga L, Borda E, Cossio P, Diez C, Arana R, Gimeno A L

出版信息

Eur J Pharmacol. 1981 Jan 5;69(1):1-10. doi: 10.1016/0014-2999(81)90596-3.

Abstract

The effects of chagasic sera, containing an antibody (EVI antibody) which reacts with the plasma membrane of working myocardial cells, on "toxic" and "non-toxic" actions of ouabain upon isolated self beating or paced rat atria suspended in different media, were explored. Although ouabain produced a dose-dependent positive inotropic influence on atria suspended in Krebs-Ringer-bicarbonate (KRB) and in KRB plus normal human serum (KRB + NHS) it did not elicit any significant positive inotropic effect on atria beating in KRB plus EVI positive human chagasic serum (EVI(+)S). Additionally, EVI(+)S dose-response curves of classical signs of digitalis cardiac toxicity shifted to the left. The threshold concentration of ouabain required to elicit the onset of "toxic" effects was higher in control preparations (kept in KRB or KRB + NHS) than in EVI(+)S exposed preparations. (-)-Propranolol attenuated the overall toxic action of ouabain in EVI(+)S and facilitated its positive inotropic influence. In control media, the beta-adrenoceptor blocker failed to modify either the "non-toxic" or the "toxic" effect of ouabain. On the other hand, with control atria, subthreshold exogenous norepinephrine inhibited the positive inotropism of ouabain. The data suggest that an adrenergic mechanism is involved in the action of ouabain on cardiac tissue immersed in an EVI(+)S-containing solution. The foregoing results may explain the severe "toxic" effects observed with cardioactive glycosides when they are used in patients with Chagas' heart disease, even at low doses.

摘要

研究了含有与工作心肌细胞质膜发生反应的抗体(EVI抗体)的恰加斯病血清,对哇巴因在悬浮于不同培养基中的离体自搏或起搏大鼠心房上的“毒性”和“非毒性”作用的影响。尽管哇巴因对悬浮于 Krebs-Ringer-碳酸氢盐(KRB)和KRB加正常人血清(KRB + NHS)中的心房产生剂量依赖性正性肌力作用,但它对在KRB加EVI阳性恰加斯病患者血清(EVI(+)S)中搏动的心房未引发任何显著的正性肌力作用。此外,洋地黄心脏毒性经典体征的EVI(+)S剂量反应曲线向左移动。引发“毒性”作用开始所需的哇巴因阈值浓度在对照制剂(保存在KRB或KRB + NHS中)中高于在暴露于EVI(+)S的制剂中。(-)-普萘洛尔减弱了哇巴因在EVI(+)S中的总体毒性作用,并促进了其正性肌力作用。在对照培养基中,β-肾上腺素能受体阻滞剂未能改变哇巴因的“非毒性”或“毒性”作用。另一方面,对于对照心房,阈下外源性去甲肾上腺素抑制了哇巴因的正性肌力作用。数据表明,肾上腺素能机制参与了哇巴因对浸泡在含EVI(+)S溶液中的心脏组织的作用。上述结果可能解释了在恰加斯心脏病患者中使用强心苷时,即使在低剂量下也观察到的严重“毒性”作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验